Cite
HARVARD Citation
Gonçalves, C. et al. (2021). Serum amyloid A protein has been undervalued as a biomarker of COVID‐19. Diabetes/metabolism research and reviews. 37 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gonçalves, C. et al. (2021). Serum amyloid A protein has been undervalued as a biomarker of COVID‐19. Diabetes/metabolism research and reviews. 37 (1), p. n/a. [Online].